PRODUCTS
ZytoDot ® SPEC MYCN Probe
The ZytoDot ® SPEC MYCN Probe is designed for the detection of MYCN amplification which represents the most powerful unfavorable prognostic factor for neuroblastoma. Less frequently amplifications are found in retinoblastoma, small cell lung cancer, astrocytoma and other tumors derived from the neuroectoderm. The MYCN oncogene is amplified in about 25% of primary neuroblastomas and 90% of tumor-derived cell lines.
Probe Maps
Ordering Information
| Prod. No.: | Tests¹ (Volume): | Registration Status²: | ||
|---|---|---|---|---|
| C-3029-400 |
|
 |
Download Information
| 1 | Using 10 μl probe solution per test. |
| 2 | In vitro diagnostic medical device according to EU directive 98/79/EC. CE IVD only available in certain countries. All other countries research use only! Please contact your local dealer for more information. |
